NeuShen Therapeutics Closes Pre-A Financing with ~$20M
/PRNewswire/ -- NeuShen Therapeutics, Inc., a biotechnology company focusing on developing innovative treatments for central nervous system (CNS) disorders...
Source: prnewswire.com
📰 Betta Pharma News
Betta Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Betta Pharma. Real-time updates on events, politics, business and more.
Biocytogen Stages $60 Million IPO
Using its animal models, Biocytogen has also developed an innovative in vivo drug efficacy and safety screening process to discover 10+ preclinical and clinical candidates.
Source: seekingalpha.com
BridGene Biosciences Announces $38.5 Million Series B Financing to Further Develop Its Next Generation Chemoproteomics Platform and First-in-Class Oncology Drugs
/PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company leveraging a proprietary chemoproteomic platform to discover and develop small-molecule...
Source: prnewswire.com
Qiming's Portfolio Company InventisBio Lists on STAR Market
/PRNewswire/ -- Qiming Venture Partners portfolio company InventisBio (SHSE: 688382), a leading company in innovative drug development, today listed on the...
Source: prnewswire.com